Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Sugano

Showing results (21-30 of 283) with videos related to

Pageof 29
Sort By:
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Direct oral anticoagulants and gastroenterologistsKentaro Sugano
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2015
[Mechanism of gastric acid secretion in relation to activation of gastric H+,K(+)-ATPase]Kentaro Sugano
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 13, 2006
Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancerKentaro Sugano
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2018
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysisKentaro Sugano
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 25, 2004
[Strategy for peptic ulcer therapy in the era of H. pylori eradication therapy]Kentaro Sugano
Journal of Gastroenterology|April 5, 2002
Rabeprazole: quest for the best PPIKentaro Sugano
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)]Kentaro Sugano
Journal of Gastroenterology|December 3, 2005
Heartburn issues burnt out?Kentaro Sugano
Best Practice & Research. Clinical Gastroenterology|December 15, 2015
Screening of gastric cancer in AsiaKentaro Sugano
Therapeutic Advances in Gastroenterology|February 1, 2018
Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to dateKentaro Sugano
Pageof 29

Showing results (21-30 of 283) with videos related to

Sort By:
Pageof 29
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Direct oral anticoagulants and gastroenterologistsKentaro Sugano
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2015
[Mechanism of gastric acid secretion in relation to activation of gastric H+,K(+)-ATPase]Kentaro Sugano
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 13, 2006
Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancerKentaro Sugano
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2018
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysisKentaro Sugano
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 25, 2004
[Strategy for peptic ulcer therapy in the era of H. pylori eradication therapy]Kentaro Sugano
Journal of Gastroenterology|April 5, 2002
Rabeprazole: quest for the best PPIKentaro Sugano
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)]Kentaro Sugano
Journal of Gastroenterology|December 3, 2005
Heartburn issues burnt out?Kentaro Sugano
Best Practice & Research. Clinical Gastroenterology|December 15, 2015
Screening of gastric cancer in AsiaKentaro Sugano
Therapeutic Advances in Gastroenterology|February 1, 2018
Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to dateKentaro Sugano
Pageof 29